BRAF V600 Mutation Detection by Immunohistochemistry Shows Tumor Homogeneity between Primary and Metastatic Sites

被引：0
|
作者：
Boursault, L.
Haddad, V.
Jouary, T.
Vergier, B.
Verdon, S.
de Mascarel, A.
Merlio, J. P.
机构：
[1] CHU, Bordeaux, France
[2] Univ Bordeaux, Bordeaux, France
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
455
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [21] Tumor Homogeneity Between Primary and Metastatic sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing
    Vergier, B.
    Boursault, L.
    Haddad, V
    Capellen, D.
    Verdon, S.
    Bellocq, J-P
    Jouary, T.
    Merlio, J-P
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 47 - 47
  • [22] Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing
    Boursault, Lucile
    Haddad, Veronique
    Vergier, Beatrice
    Cappellen, David
    Verdon, Severine
    Bellocq, Jean-Pierre
    Jouary, Thomas
    Merlio, Jean-Philippe
    PLOS ONE, 2013, 8 (08):
  • [23] Detection of BRAF V600E Mutation in Melanoma: Comparison Between Immunohistochemistry and Three Gene Mutation Detection Methods
    Xu, W.
    Shaimaa, L.
    Wakkas, F.
    James, H.
    Declan, S.
    Mohammad, I.
    Somaia, E.
    JOURNAL OF PATHOLOGY, 2020, 250 : 12 - 12
  • [24] Sensitivity of Pyrosequencing in Detecting the BRAF V600E Mutation Compared with the Cobas 4800 BRAF V600 Mutation Test
    Appin, C. L.
    Fisher, K. E.
    Hill, C. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 930 - 930
  • [25] PREVALENCE OF BRAF V600 IN PRIMARY GLIOMAS: A SYSTEMATIC REVIEW
    Andrews, Lily
    Thornton, Zak
    Saincher, Samir
    Dawson, Sarah
    Cheng, Vincent
    Higgins, Julian
    McAleenan, Alexandra
    Kurian, Kathreena
    NEURO-ONCOLOGY, 2021, 23 : 13 - 14
  • [26] NICE guidance on dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma
    Tucker, Helen
    Umeweni, Nwamaka
    Robertson, Janet
    Adam, Jane
    LANCET ONCOLOGY, 2014, 15 (13): : 1425 - 1426
  • [27] The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation
    Brown, Michael P.
    Long, Georgina V.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 1 - 15
  • [28] Detecting the V600 BRAF mutation by allele-specific PCR
    Dahse, Regine
    Kosmehl, Hartwig
    TUMOR BIOLOGY, 2012, 33 : 112 - 112
  • [29] Implementation of a National Plan in Argentina to Detect Braf V600 Mutation-Positive Metastatic Melanoma
    Latorre, M. C.
    Gutierrez, M.
    Garcia-Rivello, H. J.
    Livellaro, B.
    Lozano, G. C.
    Maldonado, C.
    Volonteri, V. I.
    De La Iglesia, P.
    Aylagas, D.
    Garritano, G.
    Carrizo, M.
    Mocetti, E. M.
    Moffa, F.
    MODERN PATHOLOGY, 2014, 27 : 136A - 136A
  • [30] Treatment of patients with advanced melanoma harboring the BRAF V600 mutation
    Polowinczak-Przybylek, Joanna
    Potemski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (01): : 48 - 52
12345